Navigation Links
Revenue360® Delivers True Healthcare Pricing Transparency and Significant ROI via its Hospital Revenue Management Solution Suite
Date:3/28/2013

(PRWEB) March 28, 2013

Beaverton, Oregon: Revenue360® hospital clients are experiencing significant benefits including true healthcare pricing transparency, increased point-of-service payments, decreased accounts receivable (A/R) days, and increased patient satisfaction. To communicate these validated benefits, Revenue360®’s has commissioned a five minute video case study describing the problem, the solution and the benefits experienced at a sample hospital. In addition to the video, Revenue360® has published a white paper supplying more detail concerning how the solution works and the benefits (financial and otherwise) that it delivers.

There has been significant coverage in the news lately regarding the lack of pricing transparency in the US healthcare system. Revenue360®’s Pricing Estimation module captures historical pricing for each procedure, by insurance plan, and aggregates this data with hospital charges and the patient’s payment information (co-pay, deductible and coinsurance) to calculate reliable pricing for patients before they are admitted for services. This enables an informed conversation with the patient to prepare them for their payment responsibility. The result surpasses “transparency” into generic hospital pricing lists which often are wildly different from the price paid by an individual patient.


Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. A Revolutionary Dietary Paradigm: New Cookbook Features A SOS-free (Salt, Oil, Sugar ) Diet That Delivers the Optimal Food Plan for Renewing Health
2. Adena Delivers Instant Health Information to Mobile Devices
3. Under-twisted DNA origami delivers cancer drugs to tumors
4. Injectable sponge delivers drugs, cells, and structure
5. John DeLuca, Ph.D., of Kessler Foundation delivers keynote at IPMSC meeting in Milan
6. For stroke patients, mechanical clot removal delivers no advantage over standard care
7. ForeCYTE Delivers Blow in the War Against Breast Cancer
8. 'LKLiveMapping' Improves Laboratory Operating Efficiency, Delivers a High First-Submission Approval of Claims, and Improves Collection
9. Young CEO Delivers Keynote Address to Inspire Collegiate Entrepreneurs at Regional Conference
10. MileageAds.com Ad Network Now Delivers Traffic To Immigration Consultants Business Websites
11. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Pools and beaches are the place to be on ... for small children, so Amica Insurance is sharing ... Centers for Disease Control and Prevention, children between the ages ... injuries and deaths. It’s important to know the best practices ... offering the following tips from the American Red Cross:, ...
(Date:7/24/2014)... -- Drinking caffeine may worsen the hot flashes and ... they go through menopause, new survey data suggests. ... limiting caffeine intake may be useful for those postmenopausal ... said researcher Dr. Stephanie Faubion, director of the Women,s ... But caffeine -- a stimulant found in coffee ...
(Date:7/24/2014)... 2014 Horizon BCBSNJ’s second annual “Back ... family a rent-free week in a beautiful Lavallette shore ... Don’t miss your chance to win a week’s vacation ... all New Jersey residents, 25 or older.* Residents can ... http://www.facebook.com/HorizonBCBSNJ . , “A family vacation at the ...
(Date:7/24/2014)... at Carnegie Mellon University, working with high-throughput data ... National Laboratory, have devised a computational method to ... breast cells turn malignant and as they respond ... analyzing how genes interact with each other in ... today by the online journal PLOS Computational ...
(Date:7/24/2014)... women who received the Human Papillomavirus Vaccination (HPV) ... of abnormal Pap test results than those who ... journal Sexually Transmitted Diseases . , ... and School of Medicine conducted a cross-sectional study ... routine cervical cytology testing. HPV status and demographic ...
Breaking Medicine News(10 mins):Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:(Beach) Sands of Time Running out to Enter Horizon Blue Cross Blue Shield of New Jersey’s 2014 “Back to the Boardwalk” Sweepstakes 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3
... been forced to revise statements made by Pope Benedict XVI ... Cameroon on March 17, the pope claimed that condom use ... pope,s comments on the Vatican,s Web site altered the comment ... of Catholics for Choice, welcomed the change as a sign ...
... hypertension, obesity, study found , , WEDNESDAY, March 18 (HealthDay News) ... than whites, a long-running study shows. , "What we found ... and it is not a rare occurrence," said Dr. Kirsten ... issue of the New England Journal of Medicine . ...
... fees to researchers and clinicians to identify study participants ... many medical schools fail to address this conflict of ... , Leslie Wolf, an associate professor of law at ... the Web sites of 117 medical schools that received ...
... finds risk of disease recurrence, death nearly twice that ... -- Obese pancreatic cancer patients are more likely than ... treat their cancer, say U.S. researchers. , "We ... 35) who were at 12-fold increased risk of lymph ...
... formalize a partnership to prevent the spread of HIV ... Russia.WASHINGTON, March 18 /PRNewswire-USNewswire/ -- ... the spread of HIV and increase access to HIV ... youth in St. Petersburg, Russia was announced by the ...
... chronic conditions most in need of help with ... survey of Californians with chronic conditions, commissioned by ... regarding the prevalence of and lack of resources ... due to the economic downturn, many of these ...
Cached Medicine News:Health News:Pope Not Infallible on Condoms 2Health News:High Rate of Early Heart Failure Seen in Blacks 2Health News:High Rate of Early Heart Failure Seen in Blacks 3Health News:Conflicts of interest in clinical research 2Health News:Obesity Tied to Poor Pancreatic Cancer Surgery Outcomes 2Health News:Partnership to Prevent HIV Among Vulnerable Russian Youth 2Health News:Partnership to Prevent HIV Among Vulnerable Russian Youth 3Health News:Many Young Adults Struggle to Manage Multiple Chronic Conditions 2Health News:Many Young Adults Struggle to Manage Multiple Chronic Conditions 3Health News:Many Young Adults Struggle to Manage Multiple Chronic Conditions 4
(Date:7/24/2014)... , July 24, 2014  IRIDEX Corporation (NASDAQ: ... release its second quarter 2014 financial results after the ... In conjunction with the release, the Company will host ... 5:00 p.m. Eastern Time on Thursday, July ... quarter and other business developments. Interested parties ...
(Date:7/24/2014)... VANCOUVER, British Columbia and MENLO PARK, ... Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") announced today ... the company,s fiscal year from December 31 to June 30. ... before September 30, 2014. Jeffrey Bacha , ... year end is an important step in achieving our goal ...
(Date:7/24/2014)... , July 24, 2014  Kinex Pharmaceuticals announced the ... the Company,s KX2-391 Ointment for the commencement of a ... the Company,s third IND to be allowed by the ... KX2-391 is a synthetic, orally active and highly selective ... KX2-391 promotes the induction of p53, G2/M arrest of ...
Breaking Medicine Technology:DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4
... trial delivery time and ensure faster access to client ... ... DATATRAK International,Inc. (Nasdaq: DATA ), a technology and services company focused ... options, flexibility and efficiency for end-users with the,DATATRAK eClinical(TM) 2008 Q1 Release., ...
... Alfacell Corporation,(Nasdaq: ACEL ) today announced that 311 ... clinical trial of its lead compound,ONCONASE, for the treatment ... Phase IIIb clinical trial was,closed on Sept. 30, 2007. ... In accordance with the statistical plan for the ...
Cached Medicine Technology:DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0 2DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0 3DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0 4DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0 5Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 2
New!...
... Electrical I/A unit for planned ... aspiration (foot control). Independent irrigation, suction, ... allows the surgeon to control all ... all functions simultaneously. Preset and actual ...
... Anterior and Posterior segment surgeries Vitrectomy-Lensectomy ... Ventury or Peristaltic Linear Aspiration. Interchangeable ... specific cutting action. Easy to read ... Cutting speed-variable from 1- 600 cuts ...
...
Medicine Products: